Cell Source, Inc
Cell Source, Inc. is a pioneering biotechnology company based in New York, focused on developing next-generation immunotherapy solutions that enable rejection-free organ transplantation and safe stem cell treatments. Utilizing their innovative Veto Cell protocols, the company addresses significant challenges in allogeneic transplantation, including donor matching, graft versus host disease, and life-threatening infections.
Under the leadership of Professor Yair Reisner, a prominent figure in immunology, Cell Source is advancing therapeutic approaches for various conditions such as leukemia, organ transplants, and non-malignant diseases like type-1 diabetes and multiple sclerosis. With a commitment to improving patient outcomes and quality of life, the company has achieved notable milestones, including the First In Human status for its Veto Cells in September 2019, and is currently conducting a Phase I/II clinical trial.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.

